ATE285251T1
Vascular endothelial cell growth factor antagonists
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 28 March 2016, 10.5 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
56 members in 15 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 41330595 | United States of America | A | |
| 9604338 | United States of America | W |
Members56
| Document | Office | Kind | |
|---|---|---|---|
| IL117645D0 | Israel | D0 | |
| CA2213833A1 | Canada | A1 | |
| CA2754887A1 | Canada | A1 | |
| CA2805588A1 | Canada | A1 | |
| WO9630046A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5378796A | Australia | A | |
| OA10149A | African Intellectual Property Organization (OAPI) | A | |
| MX9706828A | Mexico | A | |
| EP0817648A1 | European Patent Office (EPO) | A1 | |
| AU696487B2 | Australia | B2 | |
| JPH11502853A | Japan | A | |
| NZ305699A | New Zealand | A | |
| US2001021382A1 | United States of America | A1 | |
| US2002032313A1 | United States of America | A1 | |
| US2002098187A1 | United States of America | A1 | |
| US2002122797A1 | United States of America | A1 | |
| US2003023046A1 | United States of America | A1 | |
| US6582959B2 | United States of America | B2 | |
| US2003203409A1 | United States of America | A1 | |
| US2003206899A1 | United States of America | A1 | |
| EP0817648B1 | European Patent Office (EPO) | B1 | |
| AT285251T | Austria | T | |
| ATE285251T1This record | Austria | T1 | |
| DE69634079D1 | Germany | D1 | |
| EP1506787A1 | European Patent Office (EPO) | A1 | |
| DK0817648T3 | Denmark | T3 | |
| PT817648E | Portugal | E | |
| ES2233967T3 | Spain | T3 | |
| IL117645A | Israel | A | |
| EP1506787B1 | European Patent Office (EPO) | B1 | |
| AT311902T | Austria | T | |
| ATE311902T1 | Austria | T1 | |
| DE69635565D1 | Germany | D1 | |
| DE69634079T2 | Germany | T2 | |
| EP1627643A2 | European Patent Office (EPO) | A2 | |
| ES2255027T3 | Spain | T3 | |
| DE69635565T2 | Germany | T2 | |
| US2006193862A1 | United States of America | A1 | |
| US2007110755A1 | United States of America | A1 | |
| US7227004B2 | United States of America | B2 | |
| US2007154391A1 | United States of America | A1 | |
| US2007253959A1 | United States of America | A1 | |
| US2008181900A1 | United States of America | A1 | |
| US7482005B2 | United States of America | B2 | |
| US2009081232A1 | United States of America | A1 | |
| US2009169556A1 | United States of America | A1 | |
| US2010080810A1 | United States of America | A1 | |
| US2010092492A1 | United States of America | A1 | |
| US2010119523A1 | United States of America | A1 | |
| US2010316652A1 | United States of America | A1 | |
| US2010330096A1 | United States of America | A1 | |
| CA2213833C | Canada | C | |
| US2011287024A1 | United States of America | A1 | |
| US2013028911A1 | United States of America | A1 | |
| EP1627643A3 | European Patent Office (EPO) | A3 | |
| US2014377276A1 | United States of America | A1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 96910651
Titles2
- German
- ANTAGONISTE DES VASCULÄREN ENDOTHELZELLEWACHSTUMFAKTORS
- English
- VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
Classification
- CPC, 12
- C07K16/22
- A61K2039/505
- C07K14/475
- C07K16/2863
- C07K2317/73
- C07K2317/76
- C07K2319/30
- A61K38/179
- A61P27/02
- A61P35/00
- A61P37/02
- A61K38/1866
- IPC, 8
- A61K45 00
- A61K38 00
- A61K38 17
- A61K38 18
- A61K39 395
- A61P27 02
- C07K16 22
- C07K16 28